
Solvay SA (SOLB) | Financial Analysis & Statements
Solvay SA | Large-cap | Basic Materials
Solvay SA | Large-cap | Basic Materials
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
1.2B
Gross Profit
252.0M
20.27%
Operating Income
147.0M
11.83%
Net Income
83.0M
6.68%
EPS (Diluted)
€0.77
Balance Sheet Metrics
Total Assets
6.3B
Total Liabilities
4.9B
Shareholders Equity
1.4B
Debt to Equity
3.45
Cash Flow Metrics
Operating Cash Flow
113.0M
Free Cash Flow
64.0M
Revenue & Profitability Trend
Solvay SA Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 5.1B | 6.0B | 8.0B | 11.4B | 9.7B |
Cost of Goods Sold | 4.0B | 4.6B | 6.6B | 8.5B | 7.2B |
Gross Profit | 1.1B | 1.4B | 1.4B | 2.9B | 2.5B |
Gross Margin % | 22.3% | 23.0% | 17.8% | 25.6% | 25.8% |
Operating Expenses | |||||
Research & Development | 34.0M | 47.0M | 46.0M | 325.0M | 300.0M |
Selling, General & Administrative | 419.0M | 526.0M | 565.0M | 1.2B | 1.2B |
Other Operating Expenses | 38.0M | - | -171.0M | -50.0M | 13.0M |
Total Operating Expenses | 491.0M | 573.0M | 440.0M | 1.5B | 1.5B |
Operating Income | 651.0M | 803.0M | 805.0M | 1.2B | 844.0M |
Operating Margin % | 12.7% | 13.3% | 10.1% | 10.7% | 8.7% |
Non-Operating Items | |||||
Interest Income | 17.0M | 36.0M | 38.0M | 10.0M | 8.0M |
Interest Expense | 123.0M | 133.0M | 54.0M | 107.0M | 182.0M |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 320.0M | 180.0M | 1.1B | 1.1B | -844.0M |
Income Tax | 87.0M | 208.0M | 228.0M | 110.0M | 248.0M |
Effective Tax Rate % | 27.2% | 115.6% | 20.1% | 10.1% | 0.0% |
Net Income | 233.0M | 2.1B | 1.9B | 989.0M | -929.0M |
Net Margin % | 4.5% | 34.9% | 24.2% | 8.6% | -9.6% |
Key Metrics | |||||
EBITDA | 1.1B | 1.9B | 2.0B | 2.3B | 3.3B |
EPS (Basic) | €2.12 | €20.09 | €18.37 | €9.15 | €-9.32 |
EPS (Diluted) | €2.10 | €19.85 | €18.30 | €9.13 | €-9.32 |
Basic Shares Outstanding | 105000897 | 104160774 | 103744461 | 103527423 | 103139855 |
Diluted Shares Outstanding | 105000897 | 104160774 | 103744461 | 103527423 | 103139855 |
Income Statement Trend
Solvay SA Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 539.0M | 584.0M | 932.0M | 941.0M | 1.0B |
Short-term Investments | 17.0M | 127.0M | 758.0M | 1.3B | 217.0M |
Accounts Receivable | 826.0M | 840.0M | 2.0B | 1.8B | 1.3B |
Inventory | 623.0M | 642.0M | 2.1B | 1.7B | 1.2B |
Other Current Assets | - | 3.0M | 1.0M | -1.0M | 2.0M |
Total Current Assets | 2.5B | 2.7B | 7.0B | 6.8B | 4.5B |
Non-Current Assets | |||||
Property, Plant & Equipment | 407.0M | 2.3B | 11.5B | 680.0M | 582.0M |
Goodwill | 1.8B | 1.7B | 9.0B | 8.9B | 8.7B |
Intangible Assets | 218.0M | 201.0M | 2.0B | 2.1B | 2.1B |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 218.0M | 267.0M | 470.0M | 723.0M | 294.0M |
Total Non-Current Assets | 4.2B | 4.3B | 13.7B | 13.2B | 12.3B |
Total Assets | 6.7B | 7.0B | 20.7B | 20.0B | 16.8B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 810.0M | 850.0M | 2.3B | 2.1B | 1.2B |
Short-term Debt | 153.0M | 151.0M | 508.0M | 770.0M | 277.0M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 460.0M | 586.0M | 1.5B | 95.0M | 137.0M |
Total Current Liabilities | 1.9B | 2.2B | 4.9B | 5.5B | 2.8B |
Non-Current Liabilities | |||||
Long-term Debt | 1.7B | 243.0M | 2.4B | 2.5B | 3.1B |
Deferred Tax Liabilities | 136.0M | 131.0M | 558.0M | 462.0M | 487.0M |
Other Non-Current Liabilities | 53.0M | 70.0M | 304.0M | 332.0M | 96.0M |
Total Non-Current Liabilities | 3.4B | 3.5B | 5.1B | 5.7B | 6.7B |
Total Liabilities | 5.3B | 5.7B | 10.0B | 11.2B | 9.5B |
Equity | |||||
Common Stock | 237.0M | 237.0M | 1.6B | 1.6B | 1.6B |
Retained Earnings | 1.7B | 1.7B | 6.9B | 5.5B | 5.0B |
Treasury Stock | 44.0M | 15.0M | 225.0M | 232.0M | 286.0M |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 1.4B | 1.3B | 10.7B | 8.9B | 7.3B |
Key Metrics | |||||
Total Debt | 1.9B | 394.0M | 2.9B | 3.3B | 3.4B |
Working Capital | 563.0M | 522.0M | 2.1B | 1.3B | 1.7B |
Balance Sheet Composition
Solvay SA Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 233.0M | 2.1B | 1.9B | 989.0M | -929.0M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | -16.0M | 416.0M | -690.0M | -866.0M | 246.0M |
Operating Cash Flow | 280.0M | 1.2B | 1.4B | 104.0M | -795.0M |
Investing Activities | |||||
Capital Expenditures | -261.0M | -960.0M | -794.0M | -531.0M | -446.0M |
Acquisitions | -12.0M | -732.0M | 80.0M | 125.0M | 1.2B |
Investment Purchases | -13.0M | - | -14.0M | -22.0M | -46.0M |
Investment Sales | - | 0 | 0 | 2.0M | 2.0M |
Investing Cash Flow | -286.0M | -1.7B | -730.0M | -426.0M | 762.0M |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | -260.0M | -424.0M | -417.0M | -431.0M | -419.0M |
Debt Issuance | 1.7B | 3.2B | 248.0M | 248.0M | 1.0B |
Debt Repayment | -1.7B | -2.8B | -796.0M | -614.0M | -1.9B |
Financing Cash Flow | -228.0M | -344.0M | -1.0B | -952.0M | -1.5B |
Free Cash Flow | 330.0M | 847.0M | 1.1B | 863.0M | 693.0M |
Net Change in Cash | -234.0M | -818.0M | -397.0M | -1.3B | -1.5B |
Cash Flow Trend
Solvay SA Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
20.70
Forward P/E
6.66
Price to Book
2.49
Price to Sales
0.57
PEG Ratio
-0.24
Profitability Ratios
Profit Margin
2.81%
Operating Margin
10.40%
Return on Equity
11.13%
Return on Assets
4.73%
Financial Health
Current Ratio
1.33
Debt to Equity
185.12
Beta
0.66
Per Share Data
EPS (TTM)
€1.31
Book Value per Share
€10.91
Revenue per Share
€47.36
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
solb | 2.9B | 20.70 | 2.49 | 11.13% | 2.81% | 185.12 |
Syneos Health | 7.4B | 377.86 | 1.19 | -1.20% | -1.30% | 45.57 |
Solvac S.A | 1.9B | 18.45 | 0.77 | 4.16% | 2,518,580.00% | 5.96 |
Azelis Group NV | 3.1B | 17.67 | 1.12 | 6.41% | 4.01% | 77.22 |
Titan Cement | 2.7B | 13.11 | 1.51 | 12.28% | 7.88% | 36.26 |
Tessenderlo Group NV | 1.5B | 37.21 | 0.86 | -1.40% | -0.99% | 14.34 |
Financial data is updated regularly. All figures are in the company's reporting currency.